AscorLab logo — company profile

AscorLab

Founded 2019 Seed Total: $1.00M Biotechnology

General Information

Company Name AscorLab
Founded Year 2019
Industries Biotechnology
Funding Stage Seed
Social

Get notified when AscorLab moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AscorLab

AscorLab is a biotechnology startup founded in 2019 that has managed to attract significant attention from venture capitalists. The company has introduced an innovative method of mucus collection utilizing natural processes. Their technique results in mucus with flawless clarity, a delicate straw hue, and a pleasant scent, all achieved without the use of additives. This process ensures not only a high-quality product but also microbiological purity. AscorLab recently secured a PLN1.00M investment in a Seed Round on 14 August 2019 from Invento Capital, underscoring the confidence that investors have in the company's vision and technology. With its pioneering approach to mucus collection, AscorLab holds the potential to revolutionize the biotechnology industry.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1 •••• •••• 14 Aug 2019

AscorLab Alternatives & Competitors

AscorLab vs
Mucommune
Mucommune United States

Advancing Innovations to Promote Female Reproductive Health

Grant
8 employees
Biotechnology, Pharmaceutical
AscorLab vs
Inhalon Biopharma
Inhalon Biopharma United States

Inhaled immunotherapy company for the prevention and treatment of acute respiratory infections such...

Grant
15 employees
Biopharma, Biotechnology
AscorLab vs

Dedicated to the development of novel therapies to improve the lives of patients with respiratory di...

Series B
13 employees
Health Care, Health and Wellness

FAQ About AscorLab

AscorLab introduces a method of mucus collection utilizing only natural processes. Through AscorLab's innovative technique, the resulting snail slime boasts flawless clarity, a delicate straw hue, and a pleasant scent. By adopting an enhanced technology for mucus collection, AscorLab completely elim...
AscorLab was founded in 2019.
AscorLab operates in the following industries: Biotechnology.
AscorLab has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Seed.
Top alternatives and competitors to AscorLab include Mucommune, Inhalon Biopharma, Enterprise Therapeutics, Bac3Gel® Lda, Boogie Wipes. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AscorLab and Mucommune are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AscorLab and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy